Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 11 recruiting now full pipeline

Osteoporosis: full-pipeline trial registry

11 of 87 indexed Osteoporosis trials are currently recruiting.

Corpus placement: #158 of 28,707 conditions by registered trial count.

87 US clinical trials · 11 currently recruiting · #158 of 28,707 conditions by registered trial count

Osteoporosis: 87 US clinical trials tracked, 11 recruiting.

Osteoporosis is the subject of 87 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 28 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 4 of these trials.

Enrollment posture brief

Registry condition osteoporosis

OPEN 11 | RECR 13% | LATE 28 | EARLY 21 | RANK #158 | SPON 4

Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)

Glioma54.5%Alcohol Drinking47.7%Chronic Obstructive Pulmonar33.3%End Stage Renal Disease28.4%Osteoporosis (this)13%
Open-enrollment share among volume-matched conditions near Osteoporosis

Osteoporosis lists 11 open slots (13% of 87 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Osteoporosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Osteoporosis is recruiting below its size-band peers.

    11 of 87 indexed trials (12.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Osteoporosis trials is spread across many organizations.

    University of Colorado, Denver accounts for 4 of 87 trials (4.6%). 65 distinct sponsors appear on at least one study for this condition label.

  3. Typical Osteoporosis enrolment sits around 81 participants.

    Median target enrolment is 81 among the 85 trials that report a genuine target (sentinel values excluded). 47 of those (55.3%) plan for fewer than 100 participants.

  4. Osteoporosis research is mostly interventional.

    73 interventional and 14 observational studies make up this index (83.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 111Phase 210Phase 312Phase 416

Open and recent trials

87 total, page 2 of 2

COMPLETED Phase 2 92 participants

Hormone Replacement Therapy to Treat Turner Syndrome

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NCT00013546

COMPLETED 86 participants

Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index

HealthEast Care System

NCT02435147

COMPLETED NA 81 participants

Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)

Rutgers University

NCT01631292

COMPLETED Phase 2 80 participants

Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women

Massachusetts General Hospital

NCT00086619

COMPLETED Phase 1 70 participants

A Comparison Study of PF708 and Forteo in Healthy Subjects

Pfenex

NCT02656810

COMPLETED Phase 1 61 participants

3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women

University of Pittsburgh

NCT00222872

COMPLETED Phase 2 60 participants

Prevention of Bone Loss After Acute SCI by Zoledronic Acid

Northwestern University

NCT02325414

COMPLETED NA 60 participants

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Mayo Clinic

NCT00436917

COMPLETED 60 participants

Determinants of Bone Mineral Density and Metabolic Syndrome in South Asian Indian Men

Drexel University

NCT03600675

COMPLETED Phase 2 60 participants

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Duke University

NCT00301873

COMPLETED Phase 4 58 participants

Abaloparatide Before Total Knee Arthroplasty

University of Wisconsin, Madison

NCT04167163

COMPLETED NA 55 participants

Effect of Calcium Supplement Particle Size and Vitamin D Supplement on Calcium Retention in Adolescent Girls

Purdue University

NCT01005381

COMPLETED Phase 4 53 participants

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women

University of California, San Francisco

NCT00504166

COMPLETED NA 48 participants

Effect of Two Exercise Programs on Bone Strength and Architecture

University of Colorado, Denver

NCT02636530

COMPLETED 45 participants

S-32 PG 242 Short Stem

St. Louis Joint Replacement Institute

NCT05083728

COMPLETED NA 40 participants

Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur

Health Research

NCT01309399

COMPLETED Phase 1 40 participants

A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ U

NCT00709540

COMPLETED NA 35 participants

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

The Cleveland Clinic

NCT00361595

COMPLETED NA 35 participants

Effects of a 12-week Home-based Yoga on Bone and Cardiovascular Health

University of Massachusetts, Lowell

NCT04353700

COMPLETED Phase 1 32 participants

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Warner Chilcott

NCT00577850

COMPLETED 31 participants

Validation of a Revised Food Frequency Questionnaire

University of Nebraska

NCT02693184

COMPLETED Phase 3 29 participants

Secondary Prevention of Osteoporosis

Hebrew SeniorLife

NCT00421343

COMPLETED 27 participants

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

University of Medicine and Dentistry of New Jersey

NCT00176579

COMPLETED Phase 2 25 participants

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

Northwestern University

NCT02025179

COMPLETED NA 24 participants

Soluble Corn Fiber and Calcium Utilization in Adolescents

Purdue University

NCT01571440

COMPLETED 23 participants

Evaluation of Outcomes of DFine StabiliT Kyphoplasty in Vertebral Compression Fractures Due to Osteoporosis

Cedars-Sinai Medical Center

NCT01839682

COMPLETED NA 20 participants

Skeletal Response to Simulated Night Shift

University of Colorado, Denver

NCT05074277

COMPLETED Phase 4 19 participants

Does Treatment of Hypovitaminosis D Increase Calcium Absorption?

University of Wisconsin, Madison

NCT00581828

COMPLETED Phase 1 19 participants

Melatonin Osteoporosis Prevention Study

Duquesne University

NCT01152580

COMPLETED Early Phase 1 14 participants

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

University of Pittsburgh

NCT00580788

COMPLETED Phase 4 12 participants

Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)

Thomas J. Schnitzer

NCT00826228

COMPLETED NA 12 participants

PTH And Calcium Responses to Exercise (PACE) in Older Adults

University of Colorado, Denver

NCT02468817

COMPLETED Phase 4 12 participants

The Effect of Protein on Calcium Absorption and Gastric Acid Production

Yale University

NCT00719160

COMPLETED NA 10 participants

Effects of Lagenbone on Bone Mineral Density

Southern California University of Health Sciences

NCT04557553

COMPLETED NA 7 participants

A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation

Wake Forest University Health Sciences

NCT05016310

COMPLETED

Study of Low Bone Mass in Premenopausal or Perimenopausal Women

National Center for Research Resources (NCRR)

NCT00005101

COMPLETED Phase 1

The Relationship Between Vitamin D, Fingernail Thickness and Bone Density

National Center for Research Resources (NCRR)

NCT00006196

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 11
Phase 2 10
Phase 3 12
Phase 4 16

Named interventions

Most-linked intervention names on Osteoporosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
6 trials
Teriparatide Drug
5 trials
Romosozumab Drug
4 trials
Placebo Other
4 trials
zoledronic acid Drug
3 trials
Zoledronic Acid Drug
3 trials
Zoledronic acid Drug
3 trials
Vitamin D Drug
2 trials

US sites by state

Facility locations filed on Osteoporosis trials. A trial with sites in several states counts in each.

California 18 trials
Massachusetts 14 trials
Florida 13 trials
Colorado 13 trials
Pennsylvania 11 trials
Illinois 10 trials
New York 9 trials
Alabama 9 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Osteoporosis page

87 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Osteoporosis condition card totals 87 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.